Correction: Additional footage provided by The Authoritative Source – covid19.theauthoritativesource.com
Nearly four months since the first case of COVID-19 was confirmed in the United States, a glimmer of hope has emerged for treating the disease.
Early clinical trial results for the anti-viral drug remdesivir have offered hope. The drug appeared to help patients recover faster, from 15 days to 11 days. That earned remdesivir an emergency use authorization (EUA) from the FDA, allowing it to be used more broadly outside of clinical trials.
Annie Luetkemeyer, MD of the UCSF School of Medicine breaks down the findings regarding remdesivir.